Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0107 | 0 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.0246 | 0.6569 | 0.6569 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0319 | 1 | 1 |
Brugia malayi | Blistered cuticle protein 3 | 0.0246 | 0.6569 | 0.6569 |
Schistosoma mansoni | peroxidasin | 0.0246 | 0.6569 | 0.6569 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0319 | 1 | 1 |
Echinococcus multilocularis | peroxidasin | 0.0246 | 0.6569 | 0.6569 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0107 | 0 | 0.5 |
Schistosoma mansoni | peroxidasin | 0.0246 | 0.6569 | 0.6569 |
Brugia malayi | Peroxidasin | 0.0246 | 0.6569 | 0.6569 |
Brugia malayi | hypothetical protein | 0.0246 | 0.6569 | 0.6569 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0107 | 0 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.0246 | 0.6569 | 0.6569 |
Brugia malayi | Animal haem peroxidase family protein | 0.0246 | 0.6569 | 0.6569 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0319 | 1 | 1 |
Echinococcus granulosus | peroxidasin | 0.0246 | 0.6569 | 0.6569 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0319 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0246 | 0.6569 | 0.6569 |
Brugia malayi | Animal haem peroxidase family protein | 0.0246 | 0.6569 | 0.6569 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0107 | 0 | 0.5 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0107 | 0 | 0.5 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0319 | 1 | 1 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.0107 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.